ArticleFrontiers in psychology2025
Measuring unbearable psychache in suicide risk: psychometric evidence for the Italian UP3 and comparison with the psychache scales.
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Psychache, or mental pain, is considered an independent predictor of suicide risk. Recent perspectives highlight the unbearable aspect of psychache as an imminent trigger for suicidal crisis. To assess this specific dimension, the Unbearable Psychache Scale (UP3) was developed from the original Psychache Scale (PAS). Although preliminary studies investigated UP3's psychometric properties, its discriminant validity in assessing suicide risk remains unclear. Methods: Thus, two cross-sectional studies were conducted on Italian community samples to examine the factorial structure, internal consistency, and scalability of the Italian UP3, and to compare its incremental and discriminant validity with PAS13/PAS10 in identifying individuals at risk for suicide. Results: Study #1 (N = 707) confirmed the UP3's unidimensional structure, with good model fit, internal consistency, and scalability. In Study #2 (N = 257), the UP3 correlated moderately to strongly with PASs, depression, and suicide risk. ROC analyses indicated that UP3 achieved comparable accuracy to PAS13 and PAS10 for recent suicide risk (AUCs 0.75-0.83), but lower accuracy for lifetime suicidal ideation (AUC = 0.681) and behaviors (AUC = 0.777). Sensitivity analyses revealed that UP3 prioritized sensitivity over specificity, with low Positive Predictive Values across outcomes: PPV was 0.42 for recent suicidal ideation, and 0.21 for recent suicidal behaviors, compared with slightly higher but still limited values for PAS scales. Hierarchical models showed that UP3 did not demonstrate incremental validity over PAS13 in predicting either recent or lifetime suicide risk. Discussion: The UP3 appears particularly sensitive to acute unbearable psychache, performing better in detecting recent than lifetime suicide risk. Although it does not outperform PAS scales, the UP3's brevity and focus on the intolerable component of psychache make it suitable for use alongside other measures as part of a comprehensive suicide risk evaluation in clinical or large-scale contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.